185 related articles for article (PubMed ID: 10935255)
1. [Axonal damage in multiple sclerosis].
Arbizu-Urdiain T; Martínez-Yélamos A
Rev Neurol; 2000 Jun 16-30; 30(12):1223-7. PubMed ID: 10935255
[TBL] [Abstract][Full Text] [Related]
2. [Neuronal injury in multiple sclerosis].
Correale J; Meli F; Ysrraelit C
Medicina (B Aires); 2006; 66(5):472-85. PubMed ID: 17137182
[TBL] [Abstract][Full Text] [Related]
3. [Use of magnetic resonance imaging in the diagnosis and prognosis of multiple sclerosis].
Zivadinov R; Sepcić J
Lijec Vjesn; 2006; 128(9-10):295-308. PubMed ID: 17128669
[TBL] [Abstract][Full Text] [Related]
4. Pathogenesis of brain and spinal cord atrophy in multiple sclerosis.
Minagar A; Toledo EG; Alexander JS; Kelley RE
J Neuroimaging; 2004 Jul; 14(3 Suppl):5S-10S. PubMed ID: 15228754
[TBL] [Abstract][Full Text] [Related]
5. Axonal injury in the cerebral normal-appearing white matter of patients with multiple sclerosis is related to concurrent demyelination in lesions but not to concurrent demyelination in normal-appearing white matter.
Narayanan S; Francis SJ; Sled JG; Santos AC; Antel S; Levesque I; Brass S; Lapierre Y; Sappey-Marinier D; Pike GB; Arnold DL
Neuroimage; 2006 Jan; 29(2):637-42. PubMed ID: 16126413
[TBL] [Abstract][Full Text] [Related]
6. Beta-Interferon treatment does not always slow the progression of axonal injury in multiple sclerosis.
Parry A; Corkill R; Blamire AM; Palace J; Narayanan S; Arnold D; Styles P; Matthews PM
J Neurol; 2003 Feb; 250(2):171-8. PubMed ID: 12574947
[TBL] [Abstract][Full Text] [Related]
7. Imaging correlates of axonal swelling in chronic multiple sclerosis brains.
Fisher E; Chang A; Fox RJ; Tkach JA; Svarovsky T; Nakamura K; Rudick RA; Trapp BD
Ann Neurol; 2007 Sep; 62(3):219-28. PubMed ID: 17427920
[TBL] [Abstract][Full Text] [Related]
8. Putting magnetic resonance spectroscopy studies in context: axonal damage and disability in multiple sclerosis.
Matthews PM; De Stefano N; Narayanan S; Francis GS; Wolinsky JS; Antel JP; Arnold DL
Semin Neurol; 1998; 18(3):327-36. PubMed ID: 9817537
[TBL] [Abstract][Full Text] [Related]
9. Contribution of white matter lesions to gray matter atrophy in multiple sclerosis: evidence from voxel-based analysis of T1 lesions in the visual pathway.
Sepulcre J; Goñi J; Masdeu JC; Bejarano B; Vélez de Mendizábal N; Toledo JB; Villoslada P
Arch Neurol; 2009 Feb; 66(2):173-9. PubMed ID: 19204153
[TBL] [Abstract][Full Text] [Related]
10. [The evidence for primary axonal loss in multiple sclerosis].
Anthony DC; Hughes P; Perry VH
Rev Neurol; 2000 Jun 16-30; 30(12):1203-8. PubMed ID: 10935251
[TBL] [Abstract][Full Text] [Related]
11. Magnetic resonance techniques to quantify tissue damage, tissue repair, and functional cortical reorganization in multiple sclerosis.
Filippi M; Agosta F
Prog Brain Res; 2009; 175():465-82. PubMed ID: 19660674
[TBL] [Abstract][Full Text] [Related]
12. Growth-associated protein 43 in lesions and cerebrospinal fluid in multiple sclerosis.
Teunissen CE; Dijkstra CD; Jasperse B; Barkhof F; Vanderstichele H; Vanmechelen E; Polman CH; Bö L
Neuropathol Appl Neurobiol; 2006 Jun; 32(3):318-31. PubMed ID: 16640650
[TBL] [Abstract][Full Text] [Related]
13. [Axonal damage in multiple sclerosis].
Bartosik-Psujek H; Stelmasiak Z
Neurol Neurochir Pol; 2002; 36(3):505-12. PubMed ID: 12185807
[TBL] [Abstract][Full Text] [Related]
14. Axonal transection in the lesions of multiple sclerosis.
Trapp BD; Peterson J; Ransohoff RM; Rudick R; Mörk S; Bö L
N Engl J Med; 1998 Jan; 338(5):278-85. PubMed ID: 9445407
[TBL] [Abstract][Full Text] [Related]
15. Quantitative pathological evidence for axonal loss in normal appearing white matter in multiple sclerosis.
Evangelou N; Esiri MM; Smith S; Palace J; Matthews PM
Ann Neurol; 2000 Mar; 47(3):391-5. PubMed ID: 10716264
[TBL] [Abstract][Full Text] [Related]
16. Axonal damage in multiple sclerosis: a complex issue in a complex disease.
Grigoriadis N; Ben-Hur T; Karussis D; Milonas I
Clin Neurol Neurosurg; 2004 Jun; 106(3):211-7. PubMed ID: 15177770
[TBL] [Abstract][Full Text] [Related]
17. Neurological disability correlates with spinal cord axonal loss and reduced N-acetyl aspartate in chronic multiple sclerosis patients.
Bjartmar C; Kidd G; Mörk S; Rudick R; Trapp BD
Ann Neurol; 2000 Dec; 48(6):893-901. PubMed ID: 11117546
[TBL] [Abstract][Full Text] [Related]
18. [Magnetic resonance in the diagnosis and treatment of multiple sclerosis].
Rovira Cañellas A
Neurologia; 2000; 15(7):288-302. PubMed ID: 11075577
[TBL] [Abstract][Full Text] [Related]
19. In-vivo evidence for stable neuroaxonal damage in the brain of patients with benign multiple sclerosis.
Benedetti B; Rovaris M; Rocca MA; Caputo D; Zaffaroni M; Capra R; Bertolotto A; Martinelli V; Comi G; Filippi M
Mult Scler; 2009 Jul; 15(7):789-94. PubMed ID: 19465450
[TBL] [Abstract][Full Text] [Related]
20. Diffusely abnormal white matter in chronic multiple sclerosis: imaging and histopathologic analysis.
Seewann A; Vrenken H; van der Valk P; Blezer EL; Knol DL; Castelijns JA; Polman CH; Pouwels PJ; Barkhof F; Geurts JJ
Arch Neurol; 2009 May; 66(5):601-9. PubMed ID: 19433660
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
